|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
14
|
|
pubmed:dateCreated |
2008-7-16
|
|
pubmed:abstractText |
To test whether the triterpenoid 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid methyl ester (CDDO-Me) and the rexinoid LG100268 (268) prevent the formation of estrogen receptor (ER)-negative mammary tumors or either arrest the growth or cause regression of established tumors in MMTV-neu mice.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
pubmed-author:AlbiniAdrianaA,
pubmed-author:GribbleGordon WGW,
pubmed-author:HondaTadashiT,
pubmed-author:LamphWilliam WWW,
pubmed-author:LibyKarenK,
pubmed-author:RisingsongReneeR,
pubmed-author:RoyceDarlene BDB,
pubmed-author:SognoIlariaI,
pubmed-author:SpornMichael BMB,
pubmed-author:VanniniNicolaN,
pubmed-author:WilliamsCharlotte RCR,
pubmed-author:YoreMark MMM
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4556-63
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:18628471-Administration, Oral,
pubmed-meshheading:18628471-Animals,
pubmed-meshheading:18628471-Antineoplastic Agents,
pubmed-meshheading:18628471-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18628471-Cell Movement,
pubmed-meshheading:18628471-Drug Synergism,
pubmed-meshheading:18628471-Endothelial Cells,
pubmed-meshheading:18628471-Female,
pubmed-meshheading:18628471-Humans,
pubmed-meshheading:18628471-Mammary Neoplasms, Experimental,
pubmed-meshheading:18628471-Mammary Tumor Virus, Mouse,
pubmed-meshheading:18628471-Mice,
pubmed-meshheading:18628471-Mice, Transgenic,
pubmed-meshheading:18628471-Neovascularization, Pathologic,
pubmed-meshheading:18628471-Nicotinic Acids,
pubmed-meshheading:18628471-Oleanolic Acid,
pubmed-meshheading:18628471-Receptor, erbB-2,
pubmed-meshheading:18628471-Receptors, Estrogen,
pubmed-meshheading:18628471-Tetrahydronaphthalenes
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Prevention and treatment of experimental estrogen receptor-negative mammary carcinogenesis by the synthetic triterpenoid CDDO-methyl Ester and the rexinoid LG100268.
|
|
pubmed:affiliation |
Department of Pharmacology, Dartmouth Medical School, Hanover, NH 03755, USA. karen.liby@darthmouth.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
